Cargando…

Speaker 2: Pierre Blier, Canada

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616486/
http://dx.doi.org/10.1093/ijnp/pyw042.010
_version_ 1783266793222045696
collection PubMed
description
format Online
Article
Text
id pubmed-5616486
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56164862017-11-27 Speaker 2: Pierre Blier, Canada Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616486/ http://dx.doi.org/10.1093/ijnp/pyw042.010 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Speaker 2: Pierre Blier, Canada
title Speaker 2: Pierre Blier, Canada
title_full Speaker 2: Pierre Blier, Canada
title_fullStr Speaker 2: Pierre Blier, Canada
title_full_unstemmed Speaker 2: Pierre Blier, Canada
title_short Speaker 2: Pierre Blier, Canada
title_sort speaker 2: pierre blier, canada
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616486/
http://dx.doi.org/10.1093/ijnp/pyw042.010